Conversely, ER-E2 signaling may also be beneficial when E2 is linked to breast cancer cell apoptosis [162], blocking of angiogenesis [163] and, in some cases, via E2-mediated blocking of the oncogenic TGFβ pathway. The gene discussed is ESR1; the disease is breast carcinoma.